Successful Treatment of Vancomycin-Resistant Enterococcus species Bone and Joint Infection with Daptomycin Plus Beta Lactam Agents

Bone and joint infections (BJI) caused by vancomycin-resistant Enterococcus spp. (VRE) are difficult to treat due to limited antibiotic options. Although linezolid can be used for VRE treatment, it is often discontinued due to time-dependent bone marrow suppression. Daptomycin, a lipopeptide antibio...

Descripción completa

Detalles Bibliográficos
Autores principales: La, Yeon Ju, Kim, Yong Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840966/
https://www.ncbi.nlm.nih.gov/pubmed/36596688
http://dx.doi.org/10.3947/ic.2022.0106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840966/
https://www.ncbi.nlm.nih.gov/pubmed/36596688
http://dx.doi.org/10.3947/ic.2022.0106

Ejemplares similares